ARK Genomic Revolution ETF vs JPMorgan Ultra Short Income ETF — how do they compare? ARK Genomic Revolution ETF trades at $44.36, while JPMorgan Ultra Short Income ETF trades at $50.45. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, JPMorgan Ultra Short Income ETF nearer its low. Which is the better fit depends on your goals.
| ARKG | JPST | |
|---|---|---|
Sector | Sector/Thematic | Leveraged / Inverse |
52-Week High | $44.55 | $50.78 |
52-Week Low | $24.02 | $50.40 |
Trailing returns across standard periods
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →JPST is an actively managed ETF that invests in short-term, investment-grade fixed income securities. It aims to provide current income and capital preservation while maintaining high liquidity.
Read more on JPST →